UBS’s Ocera Therapeutics OCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCRX
SM
UBS's OCRX Position: Q2 2014 in Review
UBS sold out of Ocera Therapeutics (OCRX) in Q2 2014, closing a stake of 27,437 shares — an estimated $289K sold.
UBS first reported a position in OCRX in Q2 2013 and held it in 3 quarters. The position peaked at $289K in Q1 2014. 33 funds tracked by Wall St. Rank hold OCRX as of Q2 2014.
- UBS reported no remaining Ocera Therapeutics position as of Q2 2014 after selling out during the quarter.
- UBS sold 27,437 Ocera Therapeutics shares in Q2 2014, an estimated $289K.
- UBS first reported a position in Ocera Therapeutics in Q2 2013 and held it in 3 quarters.
- UBS's Ocera Therapeutics position peaked at $289K in Q1 2014.
- 33 funds tracked by Wall St. Rank held Ocera Therapeutics as of Q2 2014.
Based on UBS's 13F filing for Q2 2014, filed 14 Aug 2014.